FDA Expands Approval for Enhertu®
On December 15, 2025, the FDA expanded approval for fam-trastuzumab deruxtecan-nxki (Enhertu®, Daiichi Sankyo, Inc.) in combination with pertuzumab (Perjeta®) as...
Read More PAST ARTICLES
2025
- The Importance of Diversity in MBC Clinical Trials
- Experts Weigh in on MBC Subtypes: Hormone Receptor-Positive MBC
- Research for Metastatic Inflammatory Breast Cancer
- What Should I do if I Decide to Leave a Clinical Trial?
- Getting a Second Opinion About Your MBC
- FDA Approves Inluriyo™
- What Happens Before Starting Treatment in a Clinical Trial?
- Side Effects of MBC Treatments: Heart Problems
- What is Immunotherapy?
- Balancing the Risks and Benefits of Clinical Trial Participation
- How to Talk to Family Members About Clinical Trials
- Side Effects of MBC Treatments: Infection
- Overcoming Resistance to Hormone Therapy
- Understanding Liquid Biopsies for MBC
- Side Effects of MBC Treatments: Sleep Problems and Mental Health
- Side Effects of MBC Treatments: Hair Loss and Body Image
- Drug Repurposing: Can Drugs for Other Diseases Benefit People with MBC?
- What Should I Do if My Clinical Trial Ends Early?
- Side Effects of MBC Treatments: Lymphedema
- Are There Different Ways to Receive MBC Drugs?
- What is a Clinical Trial Navigator?
- Using Technology to Improve Quality of Life
- Side Effects of MBC Treatments: Brain Fog and Cognitive Problems
- How to Prepare for Your Visit With Your Healthcare Team
- Side Effects of MBC Treatments: Pain and Neuropathy
- Dissecting Trial Information on ClinicalTrials.gov
- Side Effects of MBC Treatments: Fatigue
2024
- What to Know About the Benefits of Sharing Your Medical Data
- Side Effects of MBC Treatments: Digestive System Side Effects
- Combining Radiation and Immunotherapy Treatment for MBC
- Can I Know if My MBC Treatment is Likely to Work?
- Different Types of Imaging Scans: Ultrasound Scans
- New Efforts and Resources to Reduce the Financial Burden of Clinical Trial Participation
- Different Types of Imaging Scans: Bone Scans
- Newly Diagnosed with MBC: Advice from People with MBC
- Decoding the Different Types of MBC Treatment
- Different Types of Imaging Scans: PET/CT Scans
- Different Types of Imaging Scans: MRI
- Tips for Vacationing or Traveling With MBC
2023
- What Are FES PET Scans and How Are They Used for Lobular Breast Cancer?
- What’s the Difference Between Targeted Therapy and Chemotherapy?
- Biomarker Testing for MBC: What, When, and How?
- Why Are MBC Outcomes Worse for Black Women Than White Women?
- Leaving a Legacy and Hope: Tissue Donation After Death
- Overcoming Resistance to CDK4/6 Inhibitors
- Researching Ways to Make MBC Treatment Easier to Tolerate
- Meet the Clinical Trial Team: The Institutional Review Board
- The Latest Research on Inflammatory Breast Cancer
- How is ER Low Used in Clinical Trials?
- Artificial Intelligence (AI) and MBC
- Meet the Clinical Trial Team: The Principal Investigator
- Living Beyond Breast Cancer Conference 2023
- Non-Treatment Trials: Managing Side Effects
- Shared Decision-Making: Collaborating with Your Doctors About Your Cancer Care
- The Latest Research on Lobular MBC
- Miami Breast Cancer Conference 2023
- Managing Other Health Conditions While Living with MBC
- Can I Participate in a MBC Clinical Trial if I Have Other Health Conditions?
- Meet the Clinical Trial Team: The Clinical Trial Coordinator
- What are Clinical Practice Guidelines and How are They Developed?
- Who are Clinical Trial Research Team Members?
- What to Know About MBC Treatment-Related Heart Problems
- What are Non-Treatment Trials and Why are They Important?
- Black Wo(Men) Speak Symposium 2022
- What is Stable Disease and How is it Monitored?
- Assembling a Healthcare Team That Hears and Respects You
- Clinical Trial Participation: The Patient’s Journey
- Metastatic Trial Search Featured in Clinical Trials Webinar
- Biomarkers to Guide MBC Treatment Decisions: ESR1, PALB2, TROP2, HRD, ctDNA, and CTCs
- I Found a Trial I’m Interested In. What’s Next?
- Does My Health Insurance Cover the Costs of Participating in a Clinical Trial?
2022
- Biomarkers to Guide MBC Treatment Decisions: dMMR/MSI-H, TMB, and NTRK Fusion
- Why You Should Consider Repeat Biopsies
- Biomarkers to Guide MBC Treatment Decisions: PIK3CA, BRCA1/BRCA2, and PD-L1/PD-1
- Lobular Breast Cancer Metastasis: Highlighting the Researchers
- Breast Cancer Lung Metastasis: Highlighting the Experts
- How To Choose a Cancer Center
2021
2020
- Giving the Right Dose of Drugs for MBC: The Patient-Centered Dosing Initiative and Project Optimus
- Creativity to Cope with MBC
- Different Types of Imaging Scans: How, When, and Why They are Used
- The Impact of MBC on Work and Career
- Side Effects of MBC Treatments: Sexual Health Side Effects
- When Should I Consider Joining a Clinical Trial?
- What is a Patient Navigator?
- Do You Know Your Rights as a Cancer Patient?
- How To Get a Newly Approved Cancer Drug
2019
SEARCH OUR SITE
for past articles or specific information.